All filters
Slidesets
Improved long acting drug delivery: What are the technologies - Andrew Owen, BSc, MSc, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Long acting HIV drugs for treatment: Data and potential implementation - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Long Acting HIV Drugs for Prevention: Data and Potential implementation - Laura Waters, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Clinical Case Presentation - Catia Marzolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Changes in drug interaction profiles for first-line HIV therapy over the 20 years of the Liverpool Drug Interaction website - Sara Gibbons
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Effect of CYP2b6 metabolizer status on levonorgestrel pharmacokinetics when combined with efavirenz-based antiretroviral therapy - Michelle Pham
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Drugs abuse and chemsex a new challenge for antiretroviral drug-drug interaction - Tess Martin
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Dual Maintenance for HIV: Con Perspective - Andrew Hill, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Dual Maintenance for HIV: Pro Perspective - José Ramón Arribas, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Introduction of Simplification- Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
WHO / Perspective on the Simplification Strategies- Philippa Easterbrook, MD, FRCP, MPH, DTM&H
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
WHA / Community Perspective on the Need for Simplification- Michael Ninburg
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Canada’s Experience with Needle Exchange Programs- Mark Tyndall, MD, ScD, FRCPC
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Monitoring and Testing, Introductory Lecture- Manal El-Sayed, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Uganda’s Experience- Kenneth Kabagambe
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Use of the HBV Viral Load Medical Prescription as a Preliminary Assessment of HBV Infection Burden in New Caledonia: a 2014-2019 Retrospective Study- P. Dény
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Mortality from Liver Diseases Associated with Hepatitis B and C in the EU/EEA – Descriptive Analysis and Estimation of 2015 Baseline- O. Mårdh
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
The Uptake of an Innovative Approach to Reduce HCV Transmission among MSM: the NoMoreC Project- T. Prinsenberg
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Model for Care - Focus on HBV, Introductory Lecture- Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Emergency Department Screening: Strategy for Elimination through an Innovative HBV and HCV Screening, Care, and Cure Program- S. Wang
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Rwanda’s Model for Care- Jean Damascene Makuza, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Changes of the Composition of the Hepatitis B Virus (HBV) surface Antigen (HBsAg) are Associated with HBsAg Loss during Nucleos(tid)e Analogues and Peg-interferon-alfa2a Treatment- M. Pfefferkorn
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Model for Care - Focus on HCV, Introductory Lecture- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Pakistan’s Model for Care- Huma Qureshi, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019